IBDEI0YT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17184,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,17184,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,17185,0)
 ;;=389.9^^92^949^39
 ;;^UTILITY(U,$J,358.3,17185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17185,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,17185,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,17185,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,17186,0)
 ;;=784.0^^92^949^38
 ;;^UTILITY(U,$J,358.3,17186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17186,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,17186,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,17186,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,17187,0)
 ;;=070.54^^92^949^40
 ;;^UTILITY(U,$J,358.3,17187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17187,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,17187,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,17187,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,17188,0)
 ;;=272.4^^92^949^41
 ;;^UTILITY(U,$J,358.3,17188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17188,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,17188,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,17188,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,17189,0)
 ;;=272.2^^92^949^42
 ;;^UTILITY(U,$J,358.3,17189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17189,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,17189,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,17189,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,17190,0)
 ;;=401.9^^92^949^43
 ;;^UTILITY(U,$J,358.3,17190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17190,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,17190,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,17190,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,17191,0)
 ;;=244.9^^92^949^44
 ;;^UTILITY(U,$J,358.3,17191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17191,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,17191,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,17191,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,17192,0)
 ;;=790.21^^92^949^45
 ;;^UTILITY(U,$J,358.3,17192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17192,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,17192,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,17192,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,17193,0)
 ;;=790.5^^92^949^51
 ;;^UTILITY(U,$J,358.3,17193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17193,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,17193,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,17193,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,17194,0)
 ;;=724.2^^92^949^52
 ;;^UTILITY(U,$J,358.3,17194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17194,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,17194,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,17194,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,17195,0)
 ;;=412.^^92^949^56
 ;;^UTILITY(U,$J,358.3,17195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17195,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,17195,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,17195,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,17196,0)
 ;;=250.60^^92^949^58
 ;;^UTILITY(U,$J,358.3,17196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17196,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,17196,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,17196,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,17197,0)
 ;;=V15.81^^92^949^59
 ;;^UTILITY(U,$J,358.3,17197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17197,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,17197,1,5,0)
 ;;=5^Noncompliance
 ;;^UTILITY(U,$J,358.3,17197,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,17198,0)
 ;;=278.00^^92^949^60
 ;;^UTILITY(U,$J,358.3,17198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17198,1,4,0)
 ;;=4^278.00
